AMNI — Amniotics AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK10.30m
- SEK2.09m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.66 | ||
| Price to Tang. Book | 1.38 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -187.09% | ||
| Return on Equity | -362.71% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Amniotics AB (publ) is a Sweden-based biotech company that develops cell therapy drugs based on mesenchymal stem cells from amniotic fluid in its in-house GMP licensed facility. Amniotics' own marker technology is used to identify and select stem cells for different tissue types; Lung (PulmoStem), Brain (CogniStem), Kidney (NephroStem), Skin (CutiStem). It allows for selecting the type of cell to be used for specific tissue. The company has developed a process - patented in all steps - which includes collection of amniotic fluid, with a medical device developed by Amniotics, followed by sorting and propagation of stem cells and packaging of product in ampoules in its own GMP facility. Amniotics is a technology and service provider to Universities, Hospitals, and the Biopharmaceutical industry.
Directors
- Peter Buhl Jensen CHM (66)
- Kare Engkilde CEO (44)
- Marcus Larsson CFD (48)
- Johny Humaloja CFO (55)
- Christer Fahraeus DRC (56)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 1st, 2015
- Public Since
- July 6th, 2021
- No. of Employees
- 6
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 2,710,547,775
- Address
- Medicon Village, Scheelevagen 2, LUND, 223 63
- Web
- https://www.amniotics.com/
- Phone
- Auditors
- Deloitte AB
Upcoming Events for AMNI
Similar to AMNI
2cureX AB
OMX Nordic Exchange Stockholm
Abliva AB
OMX Nordic Exchange Stockholm
Acousort AB
OMX Nordic Exchange Stockholm
Active Biotech AB publ
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
FAQ
What is the Amniotics AB (publ) share price?
As of Today at 19:02 UTC, shares in Amniotics AB (publ) are trading at SEK0.00. This share price information is delayed by 15 minutes.
How has the Amniotics AB (publ) share price performed this year?
Shares in Amniotics AB (publ) last closed at SEK0.00 and the price had moved by -89.65% over the past 365 days. In terms of relative price strength the Amniotics AB (publ) share price has underperformed the FTSE Global All Cap Index by -90.28% over the past year.
What are the analyst and broker recommendations for Amniotics AB (publ)?
There is no consensus recommendation for this security.
What is the Amniotics AB (publ) dividend yield?
Amniotics AB (publ) does not currently pay a dividend.
Does Amniotics AB (publ) pay a dividend?
Amniotics AB (publ) does not currently pay a dividend.
When does Amniotics AB (publ) next pay dividends?
Amniotics AB (publ) does not currently pay a dividend.
How do I buy Amniotics AB (publ) shares?
To buy shares in Amniotics AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Amniotics AB (publ)?
As of the previous close price of SEK0.00, shares in Amniotics AB (publ) had a market capitalisation of SEK10.30m.
Where are Amniotics AB (publ) shares listed?
Here are the trading details for Amniotics AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: AMNI
What kind of share is Amniotics AB (publ)?
Based on an overall assessment of its quality, value and momentum Amniotics AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Amniotics AB (publ) share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Amniotics AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amniotics AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -76.39%.
As of the last closing price of SEK0.00, shares in Amniotics AB (publ) were trading -72.11% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Amniotics AB (publ) PE Ratio?
The Amniotics AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Amniotics AB (publ)?
Amniotics AB (publ)'s management team is headed by:
- Peter Buhl Jensen - CHM
- Kare Engkilde - CEO
- Marcus Larsson - CFD
- Johny Humaloja - CFO
- Christer Fahraeus - DRC